Senate votes to delay federal ban on hemp-derived THC products for one month

What happened

The Senate voted 61-32 to table a bipartisan amendment aimed at removing a one-month delay on a federal ban for most hemp-derived THC products. The amendment, proposed by Sen. Ted Budd and other senators, was part of discussions surrounding stopgap government funding.

Why it matters

This delay affects the regulation of hemp-derived THC products, impacting producers and consumers.

How this story affects people

How does this story affect you if you are a small business owner?

A delay in the federal ban on hemp-derived THC products may provide small business owners in the cannabis industry with more time to adjust their operations and inventory. This could help them avoid potential losses from sudden regulatory changes.

How does this story affect you if you are a parent?

Parents may be concerned about the availability and regulation of hemp-derived THC products, as the delay could mean continued access to these products for their children. This situation may raise questions about safety and the potential effects of these products.

How does this story affect you if you are a patient?

Patients who use hemp-derived THC products for medical purposes may benefit from the delay, as it allows continued access to these products while regulations are being discussed. This could provide them with more time to secure necessary supplies without interruption.

Want this written about you?

The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.

Get your Ripple